MedPath

Micro-RNA Expression Profiles in High Risk Prostate Cancer

Terminated
Conditions
Prostate Cancer
Radical Prostatectomy
Registration Number
NCT01220427
Lead Sponsor
Wuerzburg University Hospital
Brief Summary

The purpose of this study is to determine whether specific Micro-RNA expression profiles are related to Prostate cancer outcome.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Male
Target Recruitment
300
Inclusion Criteria

Patients with clinically localised high risk prostate cancer (cT>2, bx GS >7, PSA >20 ng/ml) scheduled for radical prostatectomy.

Exclusion Criteria

Non high risk prostate cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrence free survivalYearly update until clinical progression

The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly for until death.

Secondary Outcome Measures
NameTimeMethod
Cancer specific survivalYearly update until death

The patients will be followed in regular time intervals in accordance with the EAU-Guidelines (2010) and the S-3 Guideline for Prostate cancer of the German Urological Association. Data will be updated once yearly until death.

Trial Locations

Locations (1)

Department of Urology and Pediatric Urology University Hospital Würzburg

🇩🇪

Würzburg, Germany

© Copyright 2025. All Rights Reserved by MedPath